Orchard Therapeutics PLC (ORTX)
NASDAQ: ORTX · IEX Real-Time Price · USD
0.584
+0.021 (3.75%)
At close: Jun 30, 2022 4:00 PM
0.589
+0.005 (0.822%)
After-hours:
Jun 30, 2022 7:10 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Revenue
|
1.68 | 2.6 | 2.51 | 2.08 | 0 | 0 |
| Revenue Growth (YoY)
|
-35.45% | 3.26% | 21.05% | - | - | - |
| Cost of Revenue
|
0.23 | 0.86 | 0.81 | 0.42 | 0 | 0 |
| Gross Profit
|
1.45 | 1.74 | 1.71 | 1.65 | 0 | 0 |
| Selling, General & Admin
|
54.91 | 64.99 | 57.22 | 31.37 | 5.99 | 3 |
| Research & Development
|
86.98 | 93.73 | 117.36 | 205.32 | 32.53 | 16.21 |
| Operating Expenses
|
141.88 | 158.72 | 174.58 | 236.69 | 38.51 | 19.2 |
| Operating Income
|
-140.43 | -156.98 | -172.87 | -235.03 | -38.51 | -19.2 |
| Interest Expense / Income
|
2.5 | 2.33 | 1.54 | 0 | 0 | 0 |
| Other Expense / Income
|
0.83 | -6.6 | -8.75 | -5.51 | 1.18 | -0.14 |
| Pretax Income
|
-143.76 | -152.71 | -165.66 | -229.53 | -39.69 | -19.07 |
| Income Tax
|
0.83 | -0.73 | -2.24 | 0.97 | 0.05 | 0.02 |
| Net Income
|
-144.58 | -151.98 | -163.42 | -230.5 | -39.74 | -19.09 |
| Net Income Common
|
-144.58 | -151.98 | -163.42 | -230.5 | -39.74 | -19.09 |
| Shares Outstanding (Basic)
|
124 | 99 | 93 | 23 | 9 | 7 |
| Shares Outstanding (Diluted)
|
124 | 99 | 93 | 23 | 9 | 7 |
| Shares Change
|
24.65% | 6.65% | 313.31% | 154.25% | 24.96% | - |
| EPS (Basic)
|
-1.17 | -1.53 | -1.75 | -10.22 | -4.48 | -2.69 |
| EPS (Diluted)
|
-1.17 | -1.53 | -1.75 | -10.22 | -4.48 | -2.69 |
| Free Cash Flow Per Share
|
-1.03 | -1.38 | -1.83 | -4.50 | -3.84 | -2.08 |
| Gross Margin
|
86.51% | 66.97% | 67.97% | 79.67% | - | - |
| Operating Margin
|
-8384.06% | -6049.25% | -6879.15% | -11321.34% | - | - |
| Profit Margin
|
-8631.88% | -5856.61% | -6503.06% | -11102.84% | - | - |
| Free Cash Flow Margin
|
-7595.76% | -5281.93% | -6784.64% | -4892.49% | - | - |
| Effective Tax Rate
|
-0.58% | 0.48% | 1.35% | -0.42% | -0.13% | -0.10% |
| EBITDA
|
-138.93 | -148.38 | -162.45 | -228.33 | -39.39 | -19.06 |
| EBITDA Margin
|
-8294.45% | -5717.84% | -6464.35% | -10998.36% | - | - |
| Depreciation & Amortization
|
2.33 | 2 | 1.68 | 1.2 | 0.3 | 0.01 |
| EBIT
|
-141.26 | -150.38 | -164.12 | -229.53 | -39.69 | -19.07 |
| EBIT Margin
|
-8433.37% | -5795.07% | -6531.00% | -11056.12% | - | - |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).